Steroid-responsive chronic hepatic graft-versus-host disease without extrahepatic graft-versus-host disease.
A 29-yr-old woman developed severe, progressive cholestasis 5 months after allogeneic bone marrow transplantation. Extrahepatic graft-versus-host disease (GVHD) was absent. Skin biopsy was equivocal 2 months after transplant, rash was absent during the period of cholestasis, and cholangiographic abnormalities were absent. Liver biopsy 7.5 months posttransplant revealed chronic hepatic GVHD. Cholestasis dramatically resolved with high dose corticosteroid therapy. Chronic hepatic GVHD occurs in the absence of overt extraintestinal GVHD and respond promptly to therapy. This underscores the importance of aggressive diagnostic evaluation of posttransplant cholestasis.
Gholson
C F
CF
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
Yau
J C
JC
LeMaistre
C F
CF
Cleary
K R
KR
D000328:Adult; D016026:Bone Marrow Transplantation; D002780:Cholestasis, Intrahepatic / Q000209:etiology*; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008099:Liver / Q000473:pathology*; D008775:Methylprednisolone / Q000627:therapeutic use*
D008775:Methylprednisolone